Mauna Kea Technologies announced today the appointment of Claire Biot, Ph.D., as an Independent Director, effective immediately. Dr Claire Biot...
Mauna Kea Technologies appoints Claire Biot, Ph.D. to board of directors
read more
Search Results
Mauna Kea Technologies reports second quarter and first half of 2020 sales
First Half of 2020 total sales down 47%; U.S. sales down 19% Second Quarter total sales down 72%; U.S. sales down 47% Sufficient...
Mauna Kea Technologies announces further strengthening of financial condition by securing €4M of non-dilutive loans guaranteed by the French state (PGE)
Mauna Kea Technologies announced that it has received financing approvals from BNP Paribas and Bpifrance for a total of €4 million in...
Mauna Kea Technologies draws down the €6m second tranche of loan agreement with the European Investment Bank (EIB)
Mauna Kea Technologies announced it has drawn down the €6m second tranche of their €22.5 million loan agreement concluded on 20 June...
Mauna Kea Technologies Announces the Launch of a First in Human Study Combining Robotic Navigational Bronchoscopy and Needle-Based Confocal Laser Endomicroscopy
The Cellvizio® 100 series system with the AQ-Flex™ 19 Confocal Miniprobe™ will be used for the assessment of peripheral lung...
Cellvizio® Endorsed by the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) as a Safe and Effective Diagnostic Tool
Analysis by SAGES Technology and Value Assessment Committee concludes that Cellvizio® has an excellent safety profile and increases the...
Mauna Kea Technologies reports full year 2019 financial results and first quarter 2020 sales results
READ THE PRESS RELEASE
Mauna Kea Technologies secures approval to access €6M second tranche of loan agreement with the European Investment Bank (EIB)
Mauna Kea Technologies announced it has obtained confirmation from the EIB of its consent to disburse the second tranche of their €22.5...
Mauna Kea Technologies to announce 2019 Full Year Results and Q1 2020 Sales on April 28, 2020
Company to host business update conference call on Tuesday, April 28, 2020, at 6:00 PM CEST (Paris time) / 1:00 PM (New York time) Mauna Kea...
Mauna Kea Technologies provides business update
As a result of the disruption from the global crisis caused by the coronavirus, or COVID-19, the company is changing its date for publication of...
Mauna Kea Technologies Receives FDA Clearance and CE Marking For Its Next-Generation Cellvizio® Platform
The new Cellvizio® platform includes significant improvements and will enable major innovations Mauna Kea Technologies announced...
Mauna Kea Technologies reports fourth quarter and full year 2019 sales
Full Year 2019 total sales up 10% Sales to clinical customers up 27%, driven by 89% growth in consumables sales related to pay-per-use...